For: | Gonzalez Ochoa AJ, Carrillo J, Manríquez D, Manrique F, Vazquez AN. Reducing hyperpigmentation after sclerotherapy: A randomized clinical trial. J Vasc Surg Venous Lymphat Disord 2021;9:154-62. [PMID: 32739509 DOI: 10.1016/j.jvsv.2020.06.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Zhu Y, Wu D, Song K, Zhu H, Li J, Sun D, Lin J. Fluoroscopy-guided foam sclerotherapy for varicose veins in the legs: a retrospective cohort analysis with long-term follow-up. J Vasc Surg Venous Lymphat Disord 2023:S2213-333X(23)00066-5. [PMID: 36906106 DOI: 10.1016/j.jvsv.2023.02.005] [Reference Citation Analysis] |
2 | Bossart S, Daneluzzi C, Cazzaniga S, Ramelet AA, Uthoff H, Seyed Jafari SM, Baumgartner M, Hunger RE, Heidemeyer K, Willenberg T. Skin hyperpigmentation after sclerotherapy with polidocanol: A systematic review. J Eur Acad Dermatol Venereol 2023;37:274-83. [PMID: 36196455 DOI: 10.1111/jdv.18639] [Reference Citation Analysis] |
3 | Kamaev A, Bulatov V, Vakhratyan P, Volkov A, Volkov A, Gavrilov E, Golovina V, Efremova O, Ivanov O, Ilyukhin E, Katorkin S, Konchugova T, Kravtsov P, Maksimov S, Mzhavanadze N, Pikhanova Z, Pryadko S, Smirnov A, Sushkov S, Chabbarov R, Shimanko A, Yakushkin S, Apkhanova T, Derkachev S, Zolotukhin I, Kalinin R, Kirienko A, Kulchitskaya D, Pelevin A, Petrikov A, Rachin A, Seliverstov E, Stoyko Y, Suchkov I. Varicose Veins. Flebol 2022;16:41. [DOI: 10.17116/flebo20221601141] [Reference Citation Analysis] |
4 | Nakano LC, Cacione DG, Baptista-Silva JC, Flumignan RL. Treatment for telangiectasias and reticular veins. Cochrane Database Syst Rev 2021;10:CD012723. [PMID: 34637138 DOI: 10.1002/14651858.CD012723.pub2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis] |
5 | Gonzalez-Ochoa AJ, Raffetto JD, Hernández AG, Zavala N, Gutiérrez O, Vargas A, Loustaunau J. Sulodexide in the Treatment of Patients with Early Stages of COVID-19: A Randomized Controlled Trial. Thromb Haemost 2021;121:944-54. [PMID: 33677827 DOI: 10.1055/a-1414-5216] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 14.5] [Reference Citation Analysis] |